PGE1 as Additive Anticoagulant in ECMO-Therapy
Phase 2
Terminated
- Conditions
- Respiratory Distress Syndrome, AdultExtracorporeal Membrane Oxygenation
- Interventions
- First Posted Date
- 2016-09-09
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- Thomas Staudinger
- Target Recruit Count
- 50
- Registration Number
- NCT02895373
- Locations
- 🇦🇹
Medical University of Vienna, Department of Medicine I, Intensive Care Unit, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath